Role Summary The Oncology Key Account Manager is a Field-based and customer-facing role with frequent travel within the assigned territory, as well as regular internal meetings. You will own territory performance for our in-label Gastrointestinal (GI) and
General Information Job Advert Title National Key Account Manager - Switzerland Location Switzerland Function/Business Area Sales Employment Class Permanent Description National Key Account Manager - Switzerland About Astellas Astellas is a global life sciences company committed to turning
Customer Experience Engages customers and patients by greeting them and offering assistance with products and services. Resolves customer issues and answers questions to ensure a positive customer experience. Models and shares customer service best practices with
Our pharmacy technician positions have undergone an exciting transformation, moving from a transaction-based environment to a much more patient-centric one. As a Walgreens Pharmacy Technician or Pharmacy Technician Apprentice, youll be front and center – interacting
Models and delivers a distinctive and delightful customer experience. Registers sales on assigned cash register, provides customers with courteous, fair, friendly, and efficient checkout service. In accordance with state and federal regulations, assists the pharmacist, under direct
Founded in 1921 and headquartered in Mendrisio (Switzerland), Sinteticas mission is to continuously strive to improve therapies by enhancing its products formulations and usability for the benefit of clinicians and patients. We do so in close
Location of role Zug, Switzerland Department Medical Affairs - EU Key Responsibilities The Autoimmune Research team has, in recent years, advanced novel therapeutic approaches to modulate and suppress the immune system in a targeted manner within
Role Summary The OncologyKey Account Manageris a Field-based and customer-facing role with frequent travel within the assigned territory, as well as regular internal meetings. You will own territory performance for our in-label Gastrointestinal(GI) andPan-TumorOncology portfolio by